The history of Viagra presents a challenging picture for shareholders. While the initial introduction generated significant gains, the lapse of its patent opened the avenue to generic versions, dramatically reducing https://telebookmarks.com/story12259433/viagra-and-big-pharma-a-volatile-opportunity